Intest Res.  2017 Jul;15(3):338-344. 10.5217/ir.2017.15.3.338.

Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases

Affiliations
  • 1Department of Internal Medicine, Seoul National University Healthcare System Gangnam Center, Seoul, Korea.
  • 2Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea. jassa@ewha.ac.kr
  • 3Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea College of Medicine, Suwon, Korea.
  • 4Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • 5Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • 6Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  • 7Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea.
  • 8Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea.
  • 9Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea.
  • 10Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea.

Abstract

BACKGROUND/AIMS
Inflammatory bowel disease (IBD) is a chronic disabling gastrointestinal disorder that diminishes the quality of life of the affected individuals. Limited data are available regarding the impact of IBD on the daily life of Koreans.
METHODS
Self-administered, computer-aided, internet-based questionnaires were distributed to members of a Korean patient organization for IBD from March to April 2013, by the Korean Association for the Study of Intestinal Diseases.
RESULTS
A total of 599 patients with IBD (387 with Crohn's disease [CD] and 212 with ulcerative colitis [UC]) were enrolled. The majority of patients (81%) expressed feelings of fatigue, weakness, and being worn out in their daily lives during times of flare; this percentage was reduced to 61% during remission. Respondents were absent from work or school for an average period of 18 days because of illness, within the first 6 months; the majority of respondents (64%) felt stressed about their absence. Forty-six percent of the respondents reported having received unfair comments at work, or having suffered discrimination. Forty-seven percent of the respondents felt that IBD had negatively affected their income and earnings. Compared with patients with UC, those with CD reported a more frequent negative impact of IBD on work, or more economic burden. More than half of the respondents (61%) reported that IBD had prevented them from making or keeping friends.
CONCLUSIONS
IBD significantly impacts daily life, including work, education, and social relationships. Treatment that addresses the full spectrum of life of a patient would be more effective.

Keyword

Inflammatory bowel disease; Crohn disease; Colitis, ulcerative; Quality of life; Surveys and questionnaires

MeSH Terms

Colitis, Ulcerative
Crohn Disease
Discrimination (Psychology)
Education
Fatigue
Friends
Humans
Inflammatory Bowel Diseases*
Intestinal Diseases*
Quality of Life
Surveys and Questionnaires

Figure

  • Fig. 1 Baseline characteristics of patients with IBD. aP <0.05, compared with patients with UC.


Cited by  1 articles

IBD2020 global forum: results of an international patient survey on quality of care
Peter Irving, Johan Burisch, Richard Driscoll, Mats Olsson, John R Fullarton, Barry S Rodgers-Gray, Simon PL Travis
Intest Res. 2018;16(4):537-545.    doi: 10.5217/ir.2018.00041.


Reference

1. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008; 14:542–549. PMID: 17941073.
Article
2. Lee JW, Im JP, Cheon JH, Kim YS, Kim JS, Han DS. Inflammatory bowel disease cohort studies in Korea: present and future. Intest Res. 2015; 13:213–218. PMID: 26130995.
Article
3. Choi JH, Kim ES, Cho KB, et al. Old age at diagnosis is associated with favorable outcomes in Korean patients with inflammatory bowel disease. Intest Res. 2015; 13:60–67. PMID: 25691844.
Article
4. Sewell JL, Velayos FS. Systematic review: the role of race and socioeconomic factors on IBD healthcare delivery and effectiveness. Inflamm Bowel Dis. 2013; 19:627–643. PMID: 22623078.
5. Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut. 2012; 61:241–247. PMID: 21646246.
Article
6. Peyrin-Biroulet L, Billioud V, D'Haens G, et al. Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process. Am J Gastroenterol. 2012; 107:1770–1776. PMID: 23211844.
Article
7. Hu PJ. Inflammatory bowel disease in Asia: the challenges and opportunities. Intest Res. 2015; 13:188–190. PMID: 26130991.
Article
8. Lönnfors S, Vermeire S, Greco M, Hommes D, Bell C, Avedano L. IBD and health-related quality of life: discovering the true impact. J Crohns Colitis. 2014; 8:1281–1286. PMID: 24662394.
9. Romberg-Camps MJ, Bol Y, Dagnelie PC, et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis. 2010; 16:2137–2147. PMID: 20848468.
Article
10. Haapamäki J, Roine RP, Sintonen H, Turunen U, Färkkilä MA, Arkkila PE. Health-related quality of life in inflammatory bowel disease measured with the generic 15D instrument. Qual Life Res. 2010; 19:919–928. PMID: 20361263.
Article
11. Sajadinejad MS, Asgari K, Molavi H, Kalantari M, Adibi P. Psychological issues in inflammatory bowel disease: an overview. Gastroenterol Res Pract. 2012; 2012:106502. PMID: 22778720.
Article
12. Hall NJ, Rubin GP, Dougall A, Hungin AP, Neely J. The fight for ‘health-related normality’: a qualitative study of the experiences of individuals living with established inflammatory bowel disease (IBD). J Health Psychol. 2005; 10:443–455. PMID: 15857873.
Article
13. Jelsness-Jørgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA. Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Aliment Pharmacol Ther. 2011; 33:106–114. PMID: 21083587.
Article
14. Yoo S, Jung YS, Park JH, et al. Fatigue severity and factors associated with high fatigue levels in Korean patients with inflammatory bowel disease. Gut Liver. 2014; 8:148–153. PMID: 24672655.
Article
15. Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology. 2010; 139:1147–1155. PMID: 20637205.
Article
16. Kim YS. What is the important issue to prevent the postoperative Crohn's disease? Intest Res. 2014; 12:85–86. PMID: 25349572.
Article
17. Danese S, Fiorino G, Mary JY, et al. Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn's disease: an IOIBD initiative. J Crohns Colitis. 2015; 9:601–606. PMID: 25908718.
Article
18. Kim ES, Kim WH. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver. 2010; 4:1–14. PMID: 20479907.
Article
19. Devlen J, Beusterien K, Yen L, Ahmed A, Cheifetz AS, Moss AC. The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model. Inflamm Bowel Dis. 2014; 20:545–552. PMID: 24407484.
20. Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis. 2010; 4:28–62. PMID: 21122489.
Article
21. Ye BD, Yang SK, Shin SJ, et al. Guidelines for the management of Crohn's disease. Intest Res. 2012; 10:26–66.
Article
22. Choi CH, Kim YH, Kim YS, et al. Guidelines for the management of ulcerative colitis. Intest Res. 2012; 10:1–25.
Article
23. Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008; 103:1989–1997. PMID: 18796096.
Article
24. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med. 2004; 66:79–84. PMID: 14747641.
Article
25. Addolorato G, Capristo E, Stefanini GF, Gasbarrini G. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol. 1997; 32:1013–1021. PMID: 9361174.
Article
26. Kim ES, Cho KB, Park KS, et al. Predictive factors of impaired quality of life in Korean patients with inactive inflammatory bowel disease: association with functional gastrointestinal disorders and mood disorders. J Clin Gastroenterol. 2013; 47:e38–e44. PMID: 23090047.
27. Bernklev T, Jahnsen J, Henriksen M, et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006; 12:402–412. PMID: 16670530.
Article
28. Daniel JM. Young adults' perceptions of living with chronic inflammatory bowel disease. Gastroenterol Nurs. 2002; 25:83–94. PMID: 12055376.
Article
29. Kemp K, Griffiths J, Lovell K. Understanding the health and social care needs of people living with IBD: a meta-synthesis of the evidence. World J Gastroenterol. 2012; 18:6240–6249. PMID: 23180944.
Article
Full Text Links
  • IR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr